Page last updated: 2024-09-05

erlotinib hydrochloride and Cancer of Testis

erlotinib hydrochloride has been researched along with Cancer of Testis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amatruda, JF; Ateek, C; Budhipramono, A; Chen, KS; Frazier, AL; Fustino, NJ; Kapur, P; Laetsch, TW; Looijenga, LHJ; Lum, L; Rakheja, D; Shukla, AA; Stroup, EK; Stuart, SH; Yamaguchi, K	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Cancer of Testis

Article	Year
EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors. Molecular cancer therapeutics, 2018, Volume: 17, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Interleukin Receptor Common gamma Subunit; Mechanistic Target of Rapamycin Complex 1; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasms, Germ Cell and Embryonal; Sirolimus; Testicular Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2018

Article

Year

EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.

Molecular cancer therapeutics, 2018, Volume: 17, Issue:5

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Interleukin Receptor Common gamma Subunit; Mechanistic Target of Rapamycin Complex 1; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasms, Germ Cell and Embryonal; Sirolimus; Testicular Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2018